Hae-duck Bae
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Therapeutic efficacy of JEW-M449, an anti-TCTP monoclonal antibody, administered via the nasal route in a BALB/c mouse model of ovalbumin-induced acute asthma.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 05, 2024
Targeting the translationally controlled tumor protein by a monoclonal antibody improves allergic airway inflammation in mice.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: July 21, 2023
Meclizine, a piperazine-derivative antihistamine, binds to dimerized translationally controlled tumor protein and attenuates allergic reactions in a mouse model.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 30, 2022
PEGylation improves the therapeutic potential of dimerized translationally controlled tumor protein blocking peptide in ovalbumin-induced mouse model of airway inflammation.
Journal: Drug delivery
Published: July 19, 2022
Optimization of formulation for enhanced intranasal delivery of insulin with translationally controlled tumor protein-derived protein transduction domain.
Journal: Drug delivery
Published: June 19, 2019
Enhanced intranasal insulin delivery by formulations and tumor protein-derived protein transduction domain as an absorption enhancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: August 01, 2018
Modified translationally controlled tumor protein-derived protein transduction domain enhances nasal delivery of exendin-4 as shown with insulin.
Journal: Drug delivery
Published: July 26, 2018
Modification of translationally controlled tumor protein-derived protein transduction domain for improved intranasal delivery of insulin.
Journal: Drug delivery
Published: April 25, 2018
Potential of Translationally Controlled Tumor Protein-Derived Protein Transduction Domains as Antigen Carriers for Nasal Vaccine Delivery.
Journal: Molecular pharmaceutics
Published: July 26, 2016
On employing a translationally controlled tumor protein-derived protein transduction domain analog for transmucosal delivery of drugs.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: January 11, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026